TY - JOUR
T1 - NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic disease
AU - Kohli, Payal
AU - Steg, Ph Gabriel
AU - Cannon, Christopher P.
AU - Smith, Sidney C.
AU - Eagle, Kim A.
AU - Ohman, E. Magnus
AU - Alberts, Mark J.
AU - Hoffman, Elaine
AU - Guo, Jianping
AU - Simon, Tabassome
AU - Sorbets, Emmanuel
AU - Goto, Shinya
AU - Bhatt, Deepak L.
N1 - Funding Information:
Funding: The REduction of Atherothrombosis for Continued Health (REACH) study was sponsored by Sanofi Aventis , Bristol-Myers Squibb , and the Waksman Foundation and is endorsed by the World Heart Federation.
PY - 2014/1
Y1 - 2014/1
N2 - Background: Nonsteroidal anti-inflammatory drugs (NSAIDs) other than aspirin have been linked to heart failure, salt retention, adverse ventricular remodeling, and thrombosis. We therefore sought to assess their impact on cardiovascular events in outpatients with stable atherothrombotic disease. Methods: We analyzed 44,095 patients in the REduction of Atherothrombosis for Continued Health (REACH) registry with information on NSAID use and 4-year follow-up. Cox proportional hazard models, including NSAID use as a time-dependent covariate, were constructed and adjusted for key baseline characteristics. End points of interest included multivariate adjusted: cardiovascular death/myocardial infarction/stroke/ischemic hospitalizations; cardiovascular death/myocardial infarction/stroke; hospitalization for heart failure; and individual components of the composite end points. Results: Compared with NSAID nonusers (n = 39,675), NSAID users (n = 4420) were older (70 vs 68 years), more frequently female and white, and had more baseline heart failure and atherosclerotic risk factors (hypertension, dyslipidemia, diabetes, reduced creatinine clearance) (all P <.001). NSAID use was associated with an increased hazard for cardiovascular death/myocardial infarction/stroke/ischemic hospitalizations (adjusted hazard ratio [adj. HR] 1.12; 95% confidence interval [CI], 1.04-1.21; P =.003) and for cardiovascular death/myocardial infarction/stroke (adj. HR 1.16; 95% CI, 1.03-1.30; P =.02). There also was a higher risk of myocardial infarction (adj. HR 1.37; 95% CI, 1.12-1.68; P =.002), stroke (adj. HR 1.21; 95% CI, 1.00-1.45; P =.048), heart failure hospitalizations (adj. HR 1.18; 95% CI, 1.03-1.34; P =.013), and ischemic hospitalizations (adj. HR 1.17; 95% CI, 1.07-1.27; P =.001). Conclusion: Among patients with stable atherothrombosis, NSAID use is associated with a higher risk of myocardial infarction, stroke, and hospitalizations for both ischemia and heart failure.
AB - Background: Nonsteroidal anti-inflammatory drugs (NSAIDs) other than aspirin have been linked to heart failure, salt retention, adverse ventricular remodeling, and thrombosis. We therefore sought to assess their impact on cardiovascular events in outpatients with stable atherothrombotic disease. Methods: We analyzed 44,095 patients in the REduction of Atherothrombosis for Continued Health (REACH) registry with information on NSAID use and 4-year follow-up. Cox proportional hazard models, including NSAID use as a time-dependent covariate, were constructed and adjusted for key baseline characteristics. End points of interest included multivariate adjusted: cardiovascular death/myocardial infarction/stroke/ischemic hospitalizations; cardiovascular death/myocardial infarction/stroke; hospitalization for heart failure; and individual components of the composite end points. Results: Compared with NSAID nonusers (n = 39,675), NSAID users (n = 4420) were older (70 vs 68 years), more frequently female and white, and had more baseline heart failure and atherosclerotic risk factors (hypertension, dyslipidemia, diabetes, reduced creatinine clearance) (all P <.001). NSAID use was associated with an increased hazard for cardiovascular death/myocardial infarction/stroke/ischemic hospitalizations (adjusted hazard ratio [adj. HR] 1.12; 95% confidence interval [CI], 1.04-1.21; P =.003) and for cardiovascular death/myocardial infarction/stroke (adj. HR 1.16; 95% CI, 1.03-1.30; P =.02). There also was a higher risk of myocardial infarction (adj. HR 1.37; 95% CI, 1.12-1.68; P =.002), stroke (adj. HR 1.21; 95% CI, 1.00-1.45; P =.048), heart failure hospitalizations (adj. HR 1.18; 95% CI, 1.03-1.34; P =.013), and ischemic hospitalizations (adj. HR 1.17; 95% CI, 1.07-1.27; P =.001). Conclusion: Among patients with stable atherothrombosis, NSAID use is associated with a higher risk of myocardial infarction, stroke, and hospitalizations for both ischemia and heart failure.
KW - Heart failure
KW - NSAID
KW - Outcomes
KW - Stable atherothrombosis
UR - http://www.scopus.com/inward/record.url?scp=84891626164&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84891626164&partnerID=8YFLogxK
U2 - 10.1016/j.amjmed.2013.08.017
DO - 10.1016/j.amjmed.2013.08.017
M3 - Article
C2 - 24280110
AN - SCOPUS:84891626164
SN - 0002-9343
VL - 127
SP - 53-60.e1
JO - American Journal of Medicine
JF - American Journal of Medicine
IS - 1
ER -